Literature DB >> 21881984

Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report.

Selim Nalbant1, Mustafa Özyurt, Murat Yıldırım, Mesih Kuskucu.   

Abstract

Tuberculosis infection (TB) is one of the most important problems for the rheumatoid arthritis (RA) patients treated with anti-TNF agents. Pulmonary tuberculosis is the most common clinic form of the TB in these patients. However, tuberculosis arthritis is very rare. We present here a 72-year-old Caucasian woman with seropositive RA, treated with etanercept/adalimumab for the last 2 years, who presented with resistant knee pain and joint effusion. We believe that this treatment caused the tuberculosis in this patient, which is the most worried complication. Interestingly, tuberculosis was in the knee joint at this time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881984     DOI: 10.1007/s00296-011-2119-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Guidelines for the management of rheumatoid arthritis: 2002 Update.

Authors: 
Journal:  Arthritis Rheum       Date:  2002-02

2.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.

Authors:  D E Furst; E C Keystone; B Kirkham; A Kavanaugh; R Fleischmann; P Mease; F C Breedveld; J S Smolen; J R Kalden; G R Burmester; J Braun; P Emery; K Winthrop; B Bresnihan; F De Benedetti; T Dörner; A Gibofsky; M H Schiff; J Sieper; N Singer; P L C M Van Riel; M E Weinblatt; M H Weisman
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

3.  Antirheumatic drugs and the risk of tuberculosis.

Authors:  Paul Brassard; Abbas Kezouh; Samy Suissa
Journal:  Clin Infect Dis       Date:  2006-08-10       Impact factor: 9.079

Review 4.  Rheumatoid arthritis.

Authors:  T D Spector
Journal:  Rheum Dis Clin North Am       Date:  1990-08       Impact factor: 2.670

Review 5.  Clinical pharmacokinetics of TNF antagonists: how do they differ?

Authors:  Ivan Nestorov
Journal:  Semin Arthritis Rheum       Date:  2005-04       Impact factor: 5.532

6.  Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong--the role of TNF blockers in an area of high tuberculosis burden.

Authors:  L-S Tam; C-C Leung; S K Ying; G K Lee; C-W Yim; Y-Y Leung; E W Kun; K-K Wong; E K Li
Journal:  Clin Exp Rheumatol       Date:  2010-10-22       Impact factor: 4.473

7.  Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

Authors:  Johan Askling; C Michael Fored; Lena Brandt; Eva Baecklund; Lennart Bertilsson; Lars Cöster; Pierre Geborek; Lennart T Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Victoria Romanus; Lars Klareskog; Nils Feltelius
Journal:  Arthritis Rheum       Date:  2005-07

Review 8.  Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.

Authors:  Michael A Gardam; Edward C Keystone; Richard Menzies; Steven Manners; Emil Skamene; Richard Long; Donald C Vinh
Journal:  Lancet Infect Dis       Date:  2003-03       Impact factor: 25.071

9.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín Mola; Maria Dolores Montero
Journal:  Arthritis Rheum       Date:  2003-08

10.  A case of tuberculous arthritis following the use of etanercept.

Authors:  Seung Won Choi; Jong Joon Ahn; Young Tae Hwang; Sang Hoon Koh; Sung Do Cho
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more
  3 in total

1.  Delayed Diagnosis: Tuberculous Arthritis of Right Knee Joint in a Patient with Rheumatoid Arthritis.

Authors:  H Senarathna; K Deshapriya
Journal:  Case Rep Rheumatol       Date:  2021-12-26

2.  20S-Hydroxyvitamin D3, a Secosteroid Produced in Humans, Is Anti-Inflammatory and Inhibits Murine Autoimmune Arthritis.

Authors:  Arnold E Postlethwaite; Robert C Tuckey; Tae-Kang Kim; Wei Li; Syamal K Bhattacharya; Linda K Myers; David D Brand; Andrzej T Slominski
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

Review 3.  Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders.

Authors:  Radomir M Slominski; Robert C Tuckey; Pulak R Manna; Anton M Jetten; Arnold Postlethwaite; Chander Raman; Andrzej T Slominski
Journal:  Genes Immun       Date:  2020-03-23       Impact factor: 2.676

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.